Clarivate 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Clarivate completed the sale of its life science and healthcare segment in October 2026, ahead of schedule, and now focuses on academia and government and IP.
- Clarivate reported $482 million of third-quarter revenue from continuing operations; year-to-date revenue was nearly $1.5 billion, with the 5% year-to-date decline attributed entirely to inorganic disposals, specifically the A and G books business.
- Third-quarter recurring organic revenue growth was 1.3%, up 110 basis points year over year, while total organic revenue growth was 0.4%. Organic ACV growth was 1.8%, up 30 basis points year over year.
- The third-quarter loss from continuing operations was $26 million, adjusted EBITDA was nearly flat year over year, and adjusted diluted EPS was 21 cents, up 3 cents from the prior year.
- Operating cash flow was $166 million and free cash flow was $110 million in the quarter; Clarivate repurchased another $75 million of notes due in 2028 at a discount of about 2%, bringing year-to-date debt reduction to $293 million.
- Adjusted EBITDA margin expanded over 300 basis points versus the same period last year, supported by organic revenue growth, strategic disposals, and disciplined cost management.
- In academia and government, organic ACV and subscription revenue growth was approximately 2%; a customer in France selected Clarivate for a multi-year modernization of its national academic system using the Alma cloud-based platform.
- Web of Science Research Intelligence secured more than 100 institutional wins across 25 countries and had an active 2026 through 2027 sales pipeline of approximately $20 million.
- In IP, recurring organic revenue grew nearly 1% and ACV returned to positive growth for the first time in over 3 years; the USPTO selected Clarivate to power image search across the US trademark register.
- Clarivate said it has more than 80 in-market AI agents, assistants, and capabilities, and its platform has handled more than 465 million AI API calls, more than 2.5 times the volume compared with this time last year.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Hello, everyone. Thank you for joining us, and welcome to the Clarivate Third Quarter 2026 Earnings Conference Call. After today's prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Mark Donohue, Vice President, Investor Relations.
Mark, please go ahead. Thank you, and good morning, everyone.
Thank you for joining us for the Clarivate Third Quarter 2026 Earnings Conference Call. As a reminder, this conference call is being recorded and webcast and is copyrighted property of Clarivate. Any rebroadcast of this information in whole or in part without prior written consent of Clarivate is prohibited. The accompanying earnings call presentation is available on the Investor Relations section of the company's website. During our call, we may make certain forward-looking statements within the meaning of applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of the business or developments in Clarivate's business to differ materially from the anticipated results, performance, achievements, or developments expressed or implied by such forward-looking statements.
Information about the factors that could cause actual results to differ materially from anticipated results or performance can be found in Clarivate's filings with the SEC and on the company's website. Our discussion will include non-GAAP measures or adjusted numbers. Clarivate believes non-GAAP results are useful in order to enhance the understanding of our ongoing operating performance, but they are a supplement to and should not be considered in isolation from or as a substitute for GAAP financial measures. Reconciliation of these measures to GAAP measures are available in our earnings release and supplemental presentation on our website. With me today are Matti Shem Tov, Chief Executive Officer, and Michael Easton, Chief Financial Officer. After our prepared remarks, we'll open up the call to your questions. With that, it's a pleasure to turn the call over to Matti.
Thank you, Mark, and thank you, everyone, for joining us. The third quarter marks a major milestone in Clarivate's continued transformation. We completed the strategic sale of Life Sciences & Healthcare segment ahead of schedule. This positions Clarivate as a more focused, higher-quality recurring business, centered on two scaled market-leading segments, Academia & Government, and IP. Both segments are driving commercial traction and customer validation from our AI-led innovation. Web of Science Research Intelligence and IPOne are strong examples of that innovation in practice. I will discuss this in more detail later. In Q2, we said that we had a building block in place to accelerate organic growth. The progress we made this quarter is a proof that we delivered on our commitments. Today's message is straightforward. We have a clear path to accelerating sustained organic growth, expanding free cash flow, and reducing leverage, all of which will continue to create long-term value for shareholders.
Q3 results reflect improving recurring revenue, strong profitability, and cash generation, continued debt reduction, and meaningful customer validation of our technology and AI capabilities. Organic ACV growth was 1.8%, up 30 basis points year over year. As a reminder, this KPI is our leading indicator for future organic revenue growth. Recurring organic revenue improved to 1.3%, an increase of 110 basis points year over year. Within A&G, organic ACV and subscription revenue growth was approximately 2%. We are excited that in France, Abes selected Clarivate to modernize its national academic library system. This multi-year agreement will replace legacy system with a unified Alma cloud-based platform that combines AI-powered discovery and library services across thousands of academic libraries and institutions.
This is a powerful validation of both the scale of our platform and the critical role Clarivate plays in the global research ecosystem. In IP, recurring organic revenue grew nearly 1%, and ACV returned to positive growth for the first time in over three years. In terms of IP wins, the USPTO selected Clarivate to power image search across the U.S. trademark register, placing our image recognition capabilities within a core trademark workflow. This reinforces the value of combining trusted proprietary data, deeply embedded workflow solution, and AI to solve the mission-critical needs of our customers. Clarivate is now a scaled, focused, and highly recurring business with $2 billion of revenue and 93% recurring organic revenue mix. Our solution span three complementary models: intelligence solution, representing 50% of revenue, workflow solution, representing 25%, and technology-enabled services, representing 25%.
This combination provides trusted decision support, embedded software, and expert-led services that customers rely on to execute critical work globally. AI is enhancing the value across these offerings. We now have more than 80 in-market AI agents, assistants, and capabilities supporting our customers at an increasing pace. Our platform has handled more than 465 million AI API calls, which is more than 2.5 times the volume compared to this time last year. This demonstrates the scale at which AI is already deployed across Clarivate, but scale of deployment is only part of the story. Clarivate's ability to apply AI to trusted content and established workflows while still maintaining trust, governance, and quality is what matters to customers. This is further evidence of why we believe AI is strongly positive for our business.
Let me turn to our two segments, starting with Academia & Government, and the strength of our position across the global research ecosystem. A&G is approximately $1.2 billion franchise, with 95% recurring organic revenue and a deeply embedded position across the global research ecosystem. Our reach is significant. 99% of the world's top 400 universities use our solutions. More than 120 million students and researchers rely on our product to enhance their outcomes, and our data powers 75% of national and regional research assessments. Our solutions are deeply embedded across research, teaching and learning, funding decisions, and lab operations. Our advantage comes from bringing together scholarly content and institutional workflows, as well as research intelligence in a proprietary ecosystem. This asset supports a resilient recurring revenue stream and creates the opportunity to build new AI-enabled products.
Web of Science Research Intelligence is a good example of what I just outlined. Following its launch in May, the platform has now secured more than 100 institutional wins across 25 countries. Importantly, we have developed an active sales pipeline for 2026 through 2027 of approximately $20 million, which we expect to continue to grow. The platform uses agentic AI to help institutions address complex questions around research strategy, impact, and funding, with output grounded in Clarivate-curated authoritative data. This matters because the decisions being made using our platform require the highest level of provenance, explainability, and trust. Early global customer traction supports our confidence in market adoption, so the next step is clear: convert that customer interest and pipeline into recurring revenue at scale. We believe these revenue opportunities are both incremental and support even stronger retention for Web of Science. Turning to intellectual property. IP is our other scaled segment, with $800 million of revenues and 90% recurring organic revenues supporting the global IP ecosystem. 90% of the top 100 R&D investors use our solutions.
More than 15,000 IP customers rely on Clarivate to manage and protect their portfolios, and 40 patent and trademark offices, including the five largest in the world, use our solutions. The work we support is non-discretionary and non-deferrable. Customers depend on Clarivate to create, protect, manage, and commercialize intellectual property globally, and to safeguard billions of dollars of intangible value with certainty and continuity. Importantly, the fundamentals of this business are improving. Recurring organic revenue grew nearly 1% in Q3, and ACV returned to positive growth. This represents continued progress and proves that we are delivering on our commitments.
Our competitive advantage comes from the combination of our IP management software, curated patent and trademark data, lifecycle services, and one of the largest teams of IP specialists in the industry. It also gives us a stronger foundation to introduce the next generation of AI agentic platform. IPOne brings that strategy to life. IPOne is becoming an AI-native intelligence layer across the IP lifecycle, combining specialized agents, Clarivate proprietary data, and trusted intelligence. It is grounded in customer proprietary IP data held within Clarivate software and inaccessible to general-purpose AI. We believe that IPOne can become the intelligence and agentic foundation across the IP lifecycle. Ahead of the November early adopter launch, we are working with more than 40 development partners across 25 countries, including more than 15 Fortune Global 500 companies.
We have established an active sales pipeline of 151 customers, which we expect to increase in the coming months. The initial release is expected to include five purpose-built AI agents and a growing library of agentic workflow skills. They are grounded in more than 1 billion interconnected data points that Clarivate has developed and enriched over decades, supported by our IP domain experts. Through the IPOne introduction, we expect to create new revenue streams and improve subscription retention. Let me bring this together. We have taken deliberate actions to improve the quality and performance of Clarivate. Our strategy is working. We have increased the recurring revenue mix of the business, improved our commercial execution, accelerated product innovation, simplified the portfolio, and reduced debt. Increasingly, we are seeing these actions reflected in our KPIs.
Recurring revenue growth is improving, IP ACV has returned to growth, and our new AI-led platforms are attracting customers and building commercial pipelines. Given the sale of Life Sciences & Healthcare, we wanted to provide an early look at 2027. The current target is to achieve higher organic ACV and recurring revenue growth alongside increasing free cash flow and lowering net leverage. We look forward to providing full 2027 guidance in February. I want to leave you with one point. Clarivate today is a different company from the one that began this transformation when I joined as CEO two years ago. With that, Michael will review our financial results in more detail.
Thank you, Matti. We continue to drive progress toward growth while focusing our portfolio on scaled recurring revenue products. We are excited that IP has returned to positive recurring organic revenue growth in the quarter, and we continue to see organic subscription revenue growth in A&G. Slide 14 is an overview of our third quarter and year-to-date results compared with the same periods last year. As a reminder, the third quarter and year-to-date financial results were impacted by the sale of the LS&H segment in October 2026, and the resulting presentation of the LS&H results as discontinued operations for all periods presented. On the waterfall schedules in the earnings presentation, we have shown the discontinued operations separately to provide visibility of our continuing operations performance and comparability to previously reported numbers. Q3 revenue from continuing operations was $482 million, bringing year-to-date to nearly $1.5 billion.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
7 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
